Related Experiment Video

Updated: Jun 19, 2026

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models
05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

A therapeutic opportunity in melanoma: ErbB4 makes a mark on skin

Jeff Settleman1

  • 1Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, USA. settleman@helix.mgh.harvard.edu

Cancer Cell
|October 6, 2009
PubMed

Insights

Malignant melanomas are aggressive tumors. A study found activated ErbB4 in 20% of cases, suggesting ErbB4 kinase inhibition as a potential therapy for these specific melanomas.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Malignant melanomas are aggressive skin cancers.
  • Conventional therapies are often ineffective against these tumors.
  • The ErbB4 receptor tyrosine kinase plays a role in cell growth and survival.

Purpose of the Study:

  • To investigate the role of ErbB4 in malignant melanoma.
  • To identify potential therapeutic targets for melanoma treatment.

Main Methods:

  • Genetic analysis of melanoma tumor samples.
  • Identification and characterization of ErbB4 mutations.
  • Assessment of ErbB4 dependency in tumor cells.

Main Results:

  • Mutationally activated ErbB4 alleles were identified in 20% of melanoma cases.
  • These tumor cells demonstrated dependency on ErbB4 signaling.
  • This suggests ErbB4 as a potential therapeutic target.

Conclusions:

  • Targeting ErbB4 kinase may be an effective treatment strategy for a subset of malignant melanomas.
  • Further research into ErbB4 inhibitors for melanoma is warranted.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: